JP5035554B2 - Antibacterial and antibacterial agents - Google Patents

Antibacterial and antibacterial agents Download PDF

Info

Publication number
JP5035554B2
JP5035554B2 JP2008080889A JP2008080889A JP5035554B2 JP 5035554 B2 JP5035554 B2 JP 5035554B2 JP 2008080889 A JP2008080889 A JP 2008080889A JP 2008080889 A JP2008080889 A JP 2008080889A JP 5035554 B2 JP5035554 B2 JP 5035554B2
Authority
JP
Japan
Prior art keywords
antibacterial
antibacterial agent
compound
acid
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008080889A
Other languages
Japanese (ja)
Other versions
JP2009234954A (en
Inventor
昌巳 尾藤
淳孝 重原
義博 片山
Original Assignee
株式会社J−ケミカル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社J−ケミカル filed Critical 株式会社J−ケミカル
Priority to JP2008080889A priority Critical patent/JP5035554B2/en
Publication of JP2009234954A publication Critical patent/JP2009234954A/en
Application granted granted Critical
Publication of JP5035554B2 publication Critical patent/JP5035554B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

本発明は優れた防菌作用を有し、かつ安全性が高く、環境に対する負荷がほとんど無い防菌剤及び抗菌剤に関する。   The present invention relates to an antibacterial agent and an antibacterial agent which have an excellent antibacterial action, are highly safe and have almost no burden on the environment.

近年では、銀イオンを利用した防菌剤、あるいは抗菌スプレー等が開発され生活用品の中にも有機化合物系の抗菌剤を添加した抗菌シート等が幅広く普及している。しかしながら、銀イオンについては毒性の問題が有り、有機化合物系の抗菌剤については、安全性の点から使用できる物質又は使用対象が限定されているのが現状である。   In recent years, antibacterial agents using silver ions, antibacterial sprays, and the like have been developed, and antibacterial sheets to which organic compound-based antibacterial agents are added are widely used in daily life. However, there is a problem of toxicity with respect to silver ions, and there are currently limited substances or objects to be used for organic compound antibacterial agents from the viewpoint of safety.

細菌(例えばサルモネラ菌)、酵母、カビ等の微生物を抑制するために動物の飼料製造や養鶏場で使用される抗菌剤の中には、ギ酸、プロピオン酸を含む抗菌剤が知られているが、ギ酸の毒性、プロピオン酸及びギ酸の不快臭が作業上問題となっている。また、pHも低いため、金属等の腐食の可能性もある。   Among the antibacterial agents used in animal feed production and poultry farms to control microorganisms such as bacteria (for example, Salmonella), yeast, and mold, antibacterial agents including formic acid and propionic acid are known. The toxicity of formic acid and the unpleasant odor of propionic acid and formic acid have become operational problems. Further, since the pH is low, there is a possibility of corrosion of metals and the like.

一方、安全性の高い天然物由来の抗菌剤も知られているが、コストや製造法に問題点を有するものが多い。天然物由来の抗菌剤としては、柑橘類由来の抗菌剤が知られている(特許文献1)。これはレモン果皮を圧搾して得られる精油を濃縮した残渣を精製して得られる化合物を有効成分とするものであるが、所望の抗菌剤とするには濃度を調整しなければならないため、製造法が煩雑で経済的でない。   On the other hand, highly safe antibacterial agents derived from natural products are also known, but many have problems in cost and production methods. As antibacterial agents derived from natural products, antibacterial agents derived from citrus fruits are known (Patent Document 1). This is a compound obtained by refining the residue obtained by concentrating the essential oil obtained by pressing lemon peel, but the concentration must be adjusted to obtain the desired antibacterial agent. The law is cumbersome and not economical.

また、マメ科植物のクロバナエンジュ抽出物を含む抗菌剤が報告されているが(特許文献2)、クロバナエンジュは栽培系の植物ではなく、かつ溶媒抽出を要するため経済的ではない。特許文献3記載の抗菌剤は、本発明と同様なタンニン由来の没食子酸を原料としているが、クラウンエーテルのような毒性の高い物質を用いる必要がある。   Moreover, although the antibacterial agent containing the cloveranaenju extract of a leguminous plant is reported (patent document 2), a cloveranaenju is not a plant of a cultivation system, and since solvent extraction is required, it is not economical. The antibacterial agent described in Patent Document 3 uses gallic acid derived from tannin as in the present invention, but it is necessary to use a highly toxic substance such as crown ether.

更には、抗菌剤の有効成分として、天然物系のフェルラ酸を原料とするフェルラ酸エステル化合物も報告されているが(特許文献4)、米糠から得られるフェルラ酸自体が高価であり、かつエステル化合物の安全性も確認されていない。
特開平8−317782号公報 特開2004−256437号公報 特開2002−161075号公報 特開2002−161004号公報
Furthermore, as an active ingredient of the antibacterial agent, a ferulic acid ester compound made from natural ferulic acid as a raw material has also been reported (Patent Document 4), but ferulic acid itself obtained from rice bran is expensive and is an ester. The safety of the compound has not been confirmed.
JP-A-8-317782 JP 2004-256437 A JP 2002-161075 A JP 2002-161004 A

従って、本発明は上記課題を解決し、安全性が極めて高く、環境に対する負荷がほとんどない防菌剤及び抗菌剤を提供することを目的とする。   Accordingly, an object of the present invention is to solve the above-mentioned problems, and to provide a bactericide and an antibacterial agent that are extremely safe and have little environmental burden.

本発明者らは、上記目的を達成するために鋭意検討した結果、下記式(I)で表される、2H−ピラン−2−オン−4,6−ジカルボン酸(以下、「PDC」と称する)のエステルが、グラム陰性菌及びグラム陽性菌に対して防菌作用及び抗菌作用を有することを見出し、本発明を完成するに至った。
すなわち、本発明は、式(I):
As a result of diligent studies to achieve the above object, the present inventors have found that 2H-pyran-2-one-4,6-dicarboxylic acid (hereinafter referred to as “PDC”) represented by the following formula (I): ) Has been found to have antibacterial and antibacterial effects against gram-negative and gram-positive bacteria, and the present invention has been completed.
That is, the present invention relates to the formula (I):

Figure 0005035554
Figure 0005035554

[式中、R及びRは各々独立に、H又はCH−(CH−OH(nは、1〜4の整数)を示す。但し、R及びRは同時にHでない。]
で表される化合物を有効成分とする防菌剤及び抗菌剤を提供するものである。
[Wherein, R 1 and R 2 each independently represent H or CH 2 — (CH 2 ) n —OH (n is an integer of 1 to 4). However, R 1 and R 2 are not H at the same time. ]
The antibacterial agent and antibacterial agent which use the compound represented by these as an active ingredient are provided.

本発明によれば、式(I)で表される化合物は優れた防菌作用及び抗菌作用を有する。
従って、式(I)で表される化合物は、天然物由来物質を出発物質としているために安全性が極めて高く、環境に対する負荷がほとんど無い防菌剤及び抗菌剤の成分として工業的に有用である。
According to the present invention, the compound represented by the formula (I) has excellent antibacterial action and antibacterial action.
Therefore, the compound represented by the formula (I) is industrially useful as a component of antibacterial and antibacterial agents, which are extremely safe because they have a natural product-derived material as a starting material, and have almost no burden on the environment. is there.

本発明の防腐剤及び抗菌剤は、式(I)で表される化合物(以下、「化合物(I)」と称する)を含むが、化合物(I)は、具体的には、R及びRが以下:R=H、かつR=CH−(CH−OH;R=CH−(CH−OH、かつR=H;又はR=CH−(CH−OH、かつR=CH−(CH−OH(但し、nは1〜4の整数)の基で表される化合物である。 The preservative and the antibacterial agent of the present invention include a compound represented by the formula (I) (hereinafter referred to as “compound (I)”). Specifically, the compound (I) includes R 1 and R 2 is the following: R 1 = H and R 2 = CH 2- (CH 2 ) n -OH; R 1 = CH 2- (CH 2 ) n -OH and R 2 = H; or R 1 = CH 2 - (CH 2) n -OH, and R 2 = CH 2 - (CH 2) n -OH ( where, n is an integer from 1 to 4) is a compound represented by the group.

化合物(I)の製造方法は特に限定されないが、例えば、バニリン、シリンガアルデヒド、バニリン酸、シリンガ酸又はプロトカテク酸を出発物質として、シュードモナス属細菌(Pseudomonas putida PbY1100)にPDCの発酵生産プラスミドpKTVLABCを導入した形質転換細胞を培養する方法(特開2005−278549号公報)を用いてPDCを製造した後、カルボン酸であるPDCとエチレングリコール等のジオール化合物との脱水反応によるエステル合成法により、簡便かつ高純度で得ることができる。 The production method of compound (I) is not particularly limited. For example, starting from vanillin, syringaldehyde, vanillic acid, syringacic acid or protocatechuic acid, PDC fermentation fermentation plasmid pKTVLABC is introduced into Pseudomonas bacteria ( Pseudomonas putida PbY1100). After producing PDC using the method of culturing the transformed cells thus introduced (Japanese Patent Application Laid-Open No. 2005-278549), it can be conveniently carried out by an ester synthesis method by dehydration reaction between carboxylic acid PDC and a diol compound such as ethylene glycol. And can be obtained with high purity.

本発明の防菌剤及び抗菌剤中の化合物(I)の含有量は、通常、0.1〜50質量%であり、好ましくは0.1〜10質量%である。   The content of the compound (I) in the antibacterial agent and antibacterial agent of the present invention is usually 0.1 to 50% by mass, preferably 0.1 to 10% by mass.

本発明の防菌剤及び抗菌剤は、各種の細菌に対して優れた防菌作用又は抗菌作用を示すが、このような細菌としては、例えば、黄色ブドウ球菌、枯草菌、コアグラーゼ陰性ブドウ球菌、レンサ球菌、腸球菌等のグラム陽性菌;大腸菌、赤痢菌、サルモネラ菌、ペスト菌等のグラム陰性菌などが挙げられる。   The antibacterial agent and antibacterial agent of the present invention exhibit excellent antibacterial or antibacterial activity against various bacteria. Examples of such bacteria include Staphylococcus aureus, Bacillus subtilis, coagulase negative staphylococci, Gram-positive bacteria such as streptococci and enterococci; Gram-negative bacteria such as Escherichia coli, Shigella, Salmonella and Plasmodium.

本発明の防菌剤及び抗菌剤は式(I)の化合物を有効成分とするが、カルボキシル基にヒドロキシアルキレン基を結合させた該化合物は、カルボン酸の酸性度が極めて低く、水溶液として中性を示すため、金属腐食等の可能性がほとんど無い。   The antibacterial and antibacterial agents of the present invention contain the compound of formula (I) as an active ingredient, but the compound having a hydroxyalkylene group bonded to a carboxyl group has a very low acidity of the carboxylic acid and is neutral as an aqueous solution. Therefore, there is almost no possibility of metal corrosion.

本発明の防菌剤及び抗菌剤は、飲食品、香粧品、口腔用品、医薬品、医薬部外品等に添加して細菌の増殖を防ぐことができ、またこれらの包装材料や、抗菌シート、抗菌加工品、抗菌スプレー等にも適用できる。   The antibacterial agent and antibacterial agent of the present invention can be added to foods and drinks, cosmetics, oral products, pharmaceuticals, quasi drugs, etc. to prevent bacterial growth, and these packaging materials, antibacterial sheets, Applicable to antibacterial processed products and antibacterial sprays.

次に実施例を挙げて本発明を詳細に説明するが、本発明はこれら実施例になんら限定されるものではない。   EXAMPLES Next, although an Example is given and this invention is demonstrated in detail, this invention is not limited to these Examples at all.

実施例1
<被験物質>
被験物質としては、PDCに過剰のエチレングリコールを反応させ、脱水縮合して得られるPDCのジエステル体を用いた。
Example 1
<Test substance>
As a test substance, a PDC diester obtained by reacting excess ethylene glycol with PDC and dehydrating and condensing it was used.

<製造例>
リービッヒ冷却管及びフットボール型撹拌子を備えた四ツ口フラスコにエチレングリコール(100 mL, 1.79 mol)を注ぎ、120℃に昇温し、ここにPDC(22.86 g, 0.12 mol)と塩酸10滴を加えて溶解させた。PDCが完全に溶解したところで、アスピレーターを用いて115 mmHgまで徐々に減圧し、副生成物の水が出なくなるまで6時間反応させた。反応後、室温まで降温し、さらに冷凍庫で冷却して白色固体を得た。得られた固体に、エタノールによる再結晶を三回行い、目的物である白色固体を得た(15.66 g、収率46.3%)。
<Production example>
Pour ethylene glycol (100 mL, 1.79 mol) into a four-necked flask equipped with a Liebig condenser and a football-type stirrer, raise the temperature to 120 ° C, and add PDC (22.86 g, 0.12 mol) and 10 drops of hydrochloric acid. In addition, it was dissolved. When PDC was completely dissolved, the pressure was gradually reduced to 115 mmHg using an aspirator, and the reaction was continued for 6 hours until no by-product water was produced. After the reaction, the temperature was lowered to room temperature, and further cooled in a freezer to obtain a white solid. The obtained solid was recrystallized with ethanol three times to obtain the target white solid (15.66 g, yield 46.3%).

<対照及び試薬>
滅菌精製水(日本薬局方精製水:日本新薬株式会社製、高圧蒸気滅菌処理)
滅菌リン酸緩衝液(PRo-media MV2-1000、(株)エルメックス)
<被検物質10%、1.0%、0.1%の各水溶液の調製>
10%水溶液:被検物質1 gを秤量し、滅菌精製水で10 mLにした。
1.0%水溶液:10%水溶液を滅菌精製水で10倍希釈した。
0.1%水溶液:10%水溶液を滅菌精製水で100倍希釈した。
<菌株>
Staphylococcus aureus subsp. aureus(スタフィロコッカス・アウレウス亜種アウレウス)(NBRC 13276)
Escherichia coli(エシェリキア・コリ)(NBRC 3972)
Salmonella Enteritidis(サルモネラ・エンテリティデス)(NBRC 3313)
括弧内は標準菌株番号を示す。
<培地>
トリプケ−スソイ寒天培地(SCD培地、日本ビオメリュー社製)
<滅菌シャーレ>
滅菌NEシャーレ(栄研器材株式会社製)
<Controls and reagents>
Sterile purified water (Japan Pharmacopoeia purified water: Nippon Shinyaku Co., Ltd., high-pressure steam sterilization treatment)
Sterile phosphate buffer (PRo-media MV2-1000, Elmex Corporation)
<Preparation of each 10%, 1.0%, and 0.1% test substances>
10% aqueous solution: 1 g of the test substance was weighed and made up to 10 mL with sterile purified water.
1.0% aqueous solution: A 10% aqueous solution was diluted 10-fold with sterilized purified water.
0.1% aqueous solution: A 10% aqueous solution was diluted 100-fold with sterilized purified water.
<Strain>
Staphylococcus aureus subsp. Aureus (Staphylococcus aureus subspecies aureus) (NBRC 13276)
Escherichia coli (NBRC 3972)
Salmonella Enteritidis (NBRC 3313)
The number in the parenthesis indicates the standard strain number.
<Medium>
Trypke Susoi Agar (SCD medium, manufactured by Biomeryu Japan)
<Sterile petri dish>
Sterilization NE Petri dish (Eiken Equipment Co., Ltd.)

<接種菌液の調製>
上記菌株をSCD寒天培地で35±2℃で18〜24時間培養後、滅菌精製水に懸濁し、MacFarland No.1の濁度に合わせたものを接種菌液とした。寒天培地を用いて寒天平板混釈法に準じて接種菌液濃度を測定した(表1)。
<Preparation of inoculum solution>
The above strain was cultured on an SCD agar medium at 35 ± 2 ° C. for 18 to 24 hours, suspended in sterilized purified water, and adjusted to the turbidity of MacFarland No. 1 as an inoculum. The concentration of the inoculum was measured using an agar medium according to the agar plate pour method (Table 1).

Figure 0005035554
Figure 0005035554

<試験手順>
被検物質10%、1.0%、0.1%の各水溶液及び滅菌精製水(対照)をそれぞれ3 mL準備した(n=1)。各試験液に0.05 mLの上記接種菌液を室温で接種した。15分間、1時間、3時間及び24時間室温で接種した後に、試験液0.5 mLを49.5 mLの滅菌リン酸緩衝液(Pro-media MV2-1000、(株)エルメックス)49.5 mLを加えて混和した。この各混和液の10倍希釈系列を作製し、生菌数を測定し、試料又は対照の1 mL中の菌数に換算した。生菌数の測定は、「第十四改正 日本薬局方 生菌数測定 寒天平板混釈法」に準じて行った。結果を表2に示す。
<Test procedure>
3 mL each of 10%, 1.0%, and 0.1% test substances and sterilized purified water (control) were prepared (n = 1). Each test solution was inoculated with 0.05 mL of the above inoculum at room temperature. After inoculating for 15 minutes, 1 hour, 3 hours and 24 hours at room temperature, add 49.5 mL of 49.5 mL of sterile phosphate buffer (Pro-media MV2-1000, Elmex Corp.) to 0.5 mL of the test solution and mix. did. A 10-fold dilution series of each mixture was prepared, the number of viable bacteria was measured, and converted to the number of bacteria in 1 mL of the sample or control. The number of viable bacteria was measured according to the “14th revision Japanese Pharmacopoeia Viable count measurement agar plate pour method”. The results are shown in Table 2.

Figure 0005035554
Figure 0005035554

表2から明らかなように、ジエステル体を含む本発明の組成物は、優れた防菌作用及び抗菌作用を示した。
また、モノエステル体やR及びRが互いに異なるジエステル体を用いても同様の結果が得られた(データ非表示)。
As is apparent from Table 2, the composition of the present invention containing a diester body exhibited excellent antibacterial and antibacterial effects.
Similar results were obtained even when monoesters or diesters having different R 1 and R 2 were used (data not shown).

Claims (2)

式(I):
Figure 0005035554
[式中、R及びRは各々独立に、H又はCH−(CH−OH(nは、1〜4の整数)を示す。但し、R及びRは同時にHでない。]
で表される化合物を有効成分とする防菌剤。
Formula (I):
Figure 0005035554
[Wherein, R 1 and R 2 each independently represent H or CH 2 — (CH 2 ) n —OH (n is an integer of 1 to 4). However, R 1 and R 2 are not H at the same time. ]
An antibacterial agent comprising a compound represented by the formula:
式(I):
Figure 0005035554
[式中、R及びRは各々独立に、H又はCH−(CH−OH(nは、1〜4の整数)を示す。但し、R及びRは同時にHでない。]
で表される化合物を有効成分とする抗菌剤。
Formula (I):
Figure 0005035554
[Wherein, R 1 and R 2 each independently represent H or CH 2 — (CH 2 ) n —OH (n is an integer of 1 to 4). However, R 1 and R 2 are not H at the same time. ]
The antibacterial agent which uses the compound represented by this as an active ingredient.
JP2008080889A 2008-03-26 2008-03-26 Antibacterial and antibacterial agents Expired - Fee Related JP5035554B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008080889A JP5035554B2 (en) 2008-03-26 2008-03-26 Antibacterial and antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008080889A JP5035554B2 (en) 2008-03-26 2008-03-26 Antibacterial and antibacterial agents

Publications (2)

Publication Number Publication Date
JP2009234954A JP2009234954A (en) 2009-10-15
JP5035554B2 true JP5035554B2 (en) 2012-09-26

Family

ID=41249377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008080889A Expired - Fee Related JP5035554B2 (en) 2008-03-26 2008-03-26 Antibacterial and antibacterial agents

Country Status (1)

Country Link
JP (1) JP5035554B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009151146A1 (en) * 2008-06-12 2009-12-17 株式会社豊田自動織機 Antibacterial agent and bactericide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5555104A (en) * 1978-10-19 1980-04-22 Nippon Synthetic Chem Ind Co Ltd:The Anti-microbial agent
JP2865302B2 (en) * 1988-02-13 1999-03-08 サントリー株式会社 2-Pyranone derivative, method for producing the same, and antibacterial agent containing the same
US20100004469A1 (en) * 2006-12-22 2010-01-07 Kabushiki Kaisha Toyota Jidoshokki Antimicrobial agents and microbicidal agents

Also Published As

Publication number Publication date
JP2009234954A (en) 2009-10-15

Similar Documents

Publication Publication Date Title
JP3007092B2 (en) Antibiotic reuterin
JP5084748B2 (en) Antibacterial and bactericidal agents
US10047381B2 (en) Method for producing 3-hydroxypropanal
CN102731301B (en) Thymol ester derivatives, its preparation method and application thereof
JPS59501950A (en) xenolhabdein antibiotic
JP6660391B2 (en) Fungicidal composition containing acetal or long-chain alkylhexytan ether
JP5035554B2 (en) Antibacterial and antibacterial agents
US9433211B2 (en) Antimicrobial agent
JP5132740B2 (en) Antibacterial agent
JP5398709B2 (en) Antibacterial and bactericidal agents
JP6583847B2 (en) Microorganisms with cellulose and starch degradability
JP2010180137A (en) Antimicrobial agent
CN110372530B (en) Compound containing alpha-substituted phenyl structure, preparation method thereof and pesticide
JP6347563B2 (en) Microorganisms selected using guaiacol recognition as an indicator and guaiacol-containing compositions having microbial growth promoting activity
CN112790195B (en) Mildew-proof adhesive and preparation method and application thereof
KR101837160B1 (en) New microorganism BT-SJP KCTC12726BP and use thereof
KR20180134128A (en) Sparassis crispa fermentation product having antioxidative and immunological activity, and preparing method thereof
EP2752416B1 (en) Novel mangromicin compound and production method therefor
RU2259369C2 (en) 5-aryl-1-phenyl-4-heteroyl-3-hydroxy-3-pyrroline-2-ones eliciting antibacterial activity
JP2011006346A (en) Antibacterial agent
CN112174908B (en) N- (arylaminoethyl) benzoxazolone compound and preparation method and application thereof
CN103012767A (en) Lauryl sorbitan ester polyoxyethylene ether iodine complex
KR101823073B1 (en) New microorganism SJP-SNU KCTC12756BP and use thereof
JP2023078911A (en) antibacterial agent
JPH07508511A (en) Fungicidal active compounds

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100426

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120418

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120522

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120612

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120612

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120619

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150713

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5035554

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150713

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees